Martine Elias is the Chief Executive Officer at Myeloma Canada, the only patient-driven, grassroots organization bringing the Canadian myeloma community together and promoting a strong, unified national voice for people living with multiple myeloma. In addition, Martine is Chair of the Collective Oncology Network for Exchange, Cancer Care Innovation, Treatment Access and Education (CONECTed), a Canadian based organization.

Formerly, Martine was the Director of Access, Advocacy, and Community Relations at Myeloma Canada where she developed, led, and executed all advocacy strategies and programs. Before that, Martine held roles as National Patient Engagement Strategy at Janssen as a member of an international working team to advance a global patient advocacy strategy, and as National Director of Community Relations, as well as a Market Access and Health Economics team leader.

Martine started her career in clinical research in the pharmaceutical industry and has since dedicated her professional life to patient advocacy, empowering the patient voice, and helping patients gain access to essential medical treatments. She is passionate about ensuring that the patient voice is included in all aspects of health policy decisions.

Martine holds a Master of Science in Biology from the University of Guelph as well as a Bachelor’s degree in Biology from l’Université de Montréal.